AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 42 announcements

Share price: ₹5,918.00
Market cap: ₹14,795 Cr
Revenue (annual): ₹2,276 Cr
Net profit (annual): ₹187.5 Cr
P/E (TTM): 87.2×Sector 47.3×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 8 Regulatory Approval 6 Legal & Regulatory 6 Other Announcement 5 Annual General Meeting 4 Financial Results 3 Results Update 2 Dividend 2 Board Meeting Date 2 Capacity Expansion 1 Business Update 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

18 Jul 2026 19:00 IST BSE

Annual Report

AstraZeneca Pharma India Annual Report

AstraZeneca Pharma India Limited released its Annual Report for the fiscal year ended March 31, 2026. The 47th Annual General Meeting is scheduled for August 10, 2026.

Read the filing ↗